Akèy › Ateroskleroz › North Carolina › Raleigh
Etid klinik pou Ateroskleroz nan Raleigh, NC
5 etid pou Ateroskleroz ap chèche patisipan nan sit nan ak bò kote Raleigh (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Ap rekriteFaz 3
- Accellacare - Raleigh, Raleigh
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Ap rekriteFaz 3
- Accellacare of Raleigh, Raleigh
A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
Ap rekriteFaz 2
- NC Heart and Vascular Research, LLC, Raleigh
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Ap rekriteFaz 2/3
- North Carolina Nephrology, PA, Raleigh
Pelacarsen Roll-over Extension Program
Ap rekriteFaz 3
- Alliance Medical Ministry, Raleigh
Etid Ateroskleroz nan lòt vil
- Boston, MA10 etid
- Houston, TX10 etid
- Washington, DC9 etid
- Orlando, FL8 etid
- Arlington, VA8 etid
- Hialeah, FL8 etid
- Durham, NC7 etid
- Memphis, TN7 etid
- Dallas, TX7 etid
- Miami, FL7 etid
- Las Vegas, NV7 etid
- Minneapolis, MN6 etid
Lòt etid nan Raleigh
- Ensifizyans kadyak7 etid
- Dyabèt Tip 26 etid
- Obèsite6 etid
- Maladi atè koronè6 etid
- Degeneresans makile6 etid
- Akidan serebavaskilè5 etid
- Kansè Endomèt5 etid
- Sipwa5 etid
- Maladi kadyovaskilè5 etid
- Dyabèt4 etid
- Edem makile4 etid
- Kansè Poumon ki pa ti selil4 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.